XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment
    Three months ended June 30,   Six months ended June 30,
Sale of Product   2018   2017 (as adjusted)   2018   2017 (as adjusted)
Radiochemical Products   $ 602,344   $ 558,817   $ 1,185,885   $ 1,172,397
Cobalt Products     324,768     84,643     652,546     304,066
Nuclear Medicine Standards     962,674     834,698     1,964,787     1,643,104
Radiological Services     502,520     307,666     1,390,114     500,465
Fluorine Products     -     -     -     -
Total Segments     2,392,306     1,785,824     5,193,332     3,620,032
Corporate revenue     -     -     -     -
Total Consolidated   $ 2,392,306   $ 1,785,824   $ 5,193,332   $ 3,620,032
                         
    Three months ended June 30,   Six months ended June 30,
Depreciation and Amortization   2018   2017 (as adjusted)   2018   2017 (as adjusted)
Radiochemical Products   $ 6,046   $ 1,609   $ 11,060   $ 3,218
Cobalt Products     753     9,084     4,796     18,854
Nuclear Medicine Standards     16,530     2,343     34,468     4,488
Radiological Services     11,918     12,567     23,957     25,005
Fluorine Products     30,725     30,751     56,820     56,846
Total Segments     65,971     56,354     131,101     108,411
Corporate depreciation and amortization     141     (1,076)     4,985     2,452
Total Consolidated   $ 66,112   $ 55,278   $ 136,086   $ 110,863
                         
    Three months ended June 30,   Six months ended June 30,
Segment Income (Loss)   2018   2017 (as adjusted)   2018   2017 (as adjusted)
Radiochemical Products   $ 103,037   $ 106,998   $ 143,557   $ 225,153
Cobalt Products     93,113     34,933     277,905     154,994
Nuclear Medicine Standards     165,294     195,661     389,236     379,633
Radiological Services     164,441     105,364     566,453     196,282
Fluorine Products     (31,613)     (56,157)     (62,912)     (141,035)
Total Segments     494,273     386,799     1,314,239     815,027
Corporate loss     (826,552)     (988,994)     (1,612,114)     (2,203,490)
Net Income   $ (332,279)   $ (602,195)   $ (297,875)   $ (1,388,463)
                         
    Three months ended June 30,   Six months ended June 30,
Expenditures for Segment Assets   2018   2017 (as adjusted)   2018   2017 (as adjusted)
Radiochemical Products   $ -   $ -   $ -   $ -
Cobalt Products     -     -     -     -
Nuclear Medicine Standards     3,914     -     22,062     (198)
Radiological Services     39,354     10,040     39,354     10,040
Fluorine Products     -     6,030     1,560     10,202
Total Segments     43,268     16,070     62,976     20,044
Corporate purchases     -     -     -     -
Total Consolidated   $ 43,268   $ 16,070   $ 62,976   $ 20,044
                         
    June 30,   December 31,            
Segment Assets   2018   2017 (as adjusted)            
Radiochemical Products   $ 315,627   $ 282,971            
Cobalt Products     2,567,851     1,813,356            
Nuclear Medicine Standards     2,288,077     2,214,061            
Radiological Services     189,138     198,437            
Fluorine Products     5,646,898     5,702,159            
Total Segments     11,007,591     10,210,984            
Corporate assets     1,463,795     1,794,310            
Total Consolidated   $ 12,471,386   $ 12,005,294